PC Pharma Limited - Colombo Stock Exchange

5.
5.1
5.2
5.3
5.4
6.
6.1
6.2
7.
7.1
7.2
7.3
8.
8.1
8.2
8.3
8.4
8.5
8.6
9.
10.
11.
12.
Future Strategies and Risk Analysis ........................................................................ 27
Future Strategies ............................................................................................................ 27
Underlying Assumptions on Which Future Strategies Are Based on ............................. 28
Market Approach ........................................................................................................... 28
Associated Risks Related to Future Strategies ............................................................... 29
Human Resources .................................................................................................. 31
Staff Strength ................................................................................................................. 31
Corporate Management Team ....................................................................................... 33
Corporate Structure .............................................................................................. 35
Share Capital Structure .................................................................................................. 35
Share Capital .................................................................................................................. 36
Shareholding Structure .................................................................................................. 37
Board of Directors ................................................................................................. 39
Profile of Directors ......................................................................................................... 40
Directors’ Interest in Shares ........................................................................................... 41
Statement – Chairman/ Chief Executive Officer ............................................................ 41
Statement – Board of Directors ..................................................................................... 41
Director’s Emoluments................................................................................................... 42
Other Disclosures ........................................................................................................... 42
Other Information Relating to the Company .......................................................... 43
Corporate Governance Practices ............................................................................ 44
Statutory Declaration ............................................................................................ 46
Statutory and Other General Information .............................................................. 47
Annexure I - Auditors Report and Financial Statements as at March 31, 2009 ................... 49
Annexure II - Auditors Report and Financial Statements as at March 31, 2010 .................. 64
Annexure III - Auditors Report and Financial Statements as at March 31, 2011 ................. 79
Annexure IV - Interim Financial Statements as at September 30, 2011 .............................. 97